Recanalization of chronic peripheral arterial occlusions by alternating intra-arterial rt-PA and PGE1

Vasa - Journal of Vascular Diseases

Volumn 27, Issue 1, 1998, Pages 20-23

  Kroger K ^a,b   Hwang, I ^a   Rudofsky, G ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Intra arterial lysis; Peripheral arterial occlusive disease; Prostaglandin E1; Recombinant tissue plasminogen activator

Indexed keywords

ALTEPLASE; GLYCERYL TRINITRATE; PROSTAGLANDIN E1; STREPTOKINASE;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; BLEEDING; CLINICAL ARTICLE; DISEASE CLASSIFICATION; EMBOLISM; FALSE ANEURYSM; FEMALE; FEMORAL ARTERY; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RECANALIZATION; RECURRENT DISEASE; RETROPERITONEAL HEMORRHAGE; TREATMENT OUTCOME;

ADULT; AGED; ALPROSTADIL; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; CHRONIC DISEASE; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEMORAL ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0031930573     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ashley S, Brooks SG, Gehani AA, Kester RC, Rees MR. Percutaneous laser recanalization of femoropopliteal occlusions using continuous wave ND-Yag laser and saphire contact probe delivery system. Eur J Vasc Surg 1994; 8: 494-501.
2. Bero CJ, Cardella JF, Reddy K, Fox PS, Healy DA, Jaffe J, Nicholas GG. Recombinant tissue plasminogen activator for the treatment of lower extremity peripheral vascular disease. J Vasc Interv Radiol 1995; 6: 571-577.
3. Bertuch H, Pilger E, Stark G, Lammer J. Selektive Thrombolyse mit rekombinanten Gewebsplasminogenaktivator in Kombination mit Prostaglandin E1. VASA 1987, Suppl. 22: 240.
4. Dotter CT, Rösch J, Seaman AJ. Selective clot lysis with low-dose streptokinase. Radiology 1974; 111: 31-37.
5. Earnshaw JJ, Westby JC, Gregsont RHS, Makin GS, Hopkinson BR. Local thrombolytic therapy of acute peripheral arterial ischemia with tissue plasminogen activator: a dose-ranging study. Br J Surg 1988; 75: 1196-1200.
6. Fischer M, Beer D, von Wrangell U. Local infiltration thrombolysis of arterial occlusions with tissue plasminogen activator. Med Klin 1992; 87: 563-566.
7. Groar RA, Risius B, Lucas FV, Young JR, Ruschhaupt WF, Beven EG, Grossbard EB. Thrombolysis with recombinant human tissue-type plasminogen activator in patients with peripheral artery and bypass graft occlusions. Circulation 1986: 74; 1-15.
8. Hess H, Mietaschk A, Bilderling VP, Neller P. Peripheral arterial occlusions: local low-dose thrombolytic therapy with recombinant tissue-type plasminogen activator. Eur J Vasc Endovasc Surg 1996; 12: 97-104.
9. Humphrey WR, Schaub RG. Effect of intravenous prostaglandin E1 on thrombolysis induced by human recombinant tissue-type plasminogen activator in feline peripheral arterial thrombosis. Fibrinolysis 1991; 5: 71-79.
10. Katzen BT, van Breda A. Low dose streptokinase in the treatment of arterial occlusions. AJR 1981; 136: 1171-1178.
11. Krause FJ, Endsin O. Local catheter-mediated lysis of the femoral artery:rt-PA-versus urokinase. Rofö Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 1993; 158: 46-48.
12. Krepel VM, Andel van GJ, Erp van WFM, Breslau PJ. Percutaneous transluminal angioplasty of the femoropopliteal artery: initial and long-term results. Radiology 1985; 156: 325-328.
13. Krupski WC, Feldman RK, Rapp JH. Recombinant human tissue-type plasminogen activator is an effective agent for thrombolysis of peripheral arteries and bypass grafts: preliminary report. J Vasc Surg 1989; 10: 491-500.
14. Lammer J, Pilger E, Neumayer K, Schreyer H. Intraarterial fibrinolysis: Long-term results. Radiology 1986; 161: 159-163.
15. Mevissen MW, Kinney EV, Bandyk DF, Reifsnyder T, Seabrook GR, Lichik EO, Towne JB. The role of duplex scanning versus angiography in predicting outcome after ballon angioplasty in the femoropopliteal artery. J Vasc Surg 1992; 15: 860-866.
16. Meyerovitz MF, Goldhaber SZ, Reagan K, Polak JF, Kandarpa K, Grassi CL, Donovan BC, Bettmann MA, Harrington DP. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions. A randomised trial. Radiology 1990; 175: 75-78.
17. Morgenstern BR, Getrajdman GI, Laffey KJ, Bixon R, Martin EC. Total occlusions of the femoropopliteal artery: High technical success rate of conventional ballon angioplasty. Radiology 1989; 172: 937-940.
18. Odink HF, Valois HC, Eikelboom BC. Femoropopliteal arterial occlusions: Laser-assisted versus conventional percutaneous transluminal angioplasty. Radiology 1991; 181: 61-66.
19. Pilger E, Lammer J, Stark G, Decrinis M, Obernosterer A, Lafer M, Pieber D, Rumpel F. Laser-angioplastie kombiniert mit Ballondilatation bei chronischer PAVK - Langzeitergebnisse nach 3 Jahren. VASA 1990; Suppl 30: 191-193.
20. Reekers JA, Kromhout JG, Jacobs MJHM. Percutaneous interventional extraluminal recanalization of the femoropopliteal artery. Eur J Vasc Surg 1994; 8: 723-728.
21. Risius B, Groar RA, Geisinger MA, Zelch MG, Lucas FV, Young JR: Thrombolytic therapy with recombinant human tissue-type plasminogen activator. Radiology 1987; 164: 465-468.
22. Rudofsky G. Beeinflussung der Kollateralarterien durch intraarterielle Prostaglandin-E1-Infusion. VASA 1987; Suppl 20, 165.
23. Schweizer J, Altmann E, Stosslein F, Florek HJ, Kaulen R. Comparison of tissue plasminogen activator and urokinase in the local infiltration thrombolysis of peripheral arterial occlusions. Eur J Radiol 1996; 22: 129-132.
24. Sinzinger H, Fitscha P. Influence of prostaglandin E1 on in vivo accumulation of radiolabelled platelets and LDL on human arteries. VASA 1987; 17: 5-9.
25. Stein U, Amendt K, Wagner E, Hild R. Catheter lysis in advanced peripheral OAD-Procedure of choice or last resort. VASA 1987; 16: 358-361.
26. Stein U, Reichardt M, Wagner E. Prognostische Kriterien für die initiale Erfolgsrate bei PTA und Katheterthrombolyse. VASA 1994; 23: 10-14.
27. Terres W, Beythien C, Kupper W, Bleifeld W. Effects of aspirin and prostaglandin E1 on in vitro thrombolysis with urokinase. Circulation 1989; 79: 1309-1314.
28. Vallbracht C, Liermann DD, Prignitz I, Beinborn W, Roth FJ, Kollath J, Landgraf H, Kaltenbach M. Low-speed rotational angioplasty in chronic peripheral artery occlusions: Experience in 83 patients. Radiology 1989; 172: 327-330.
29. Vaughan DE, Plavin SR, Schäfer AI, Loscalzo J. PGE1 accelerates thrombolysis by tissue plasminogen activator. Blood 1989; 73: 1213-1217.